Company Filing History:
Years Active: 2013-2024
Title: Emily Turner: Innovator in DNA Sequencing Technologies
Introduction
Emily Turner is a prominent inventor based in Seattle, WA (US), known for her significant contributions to the field of DNA sequencing. With a total of 7 patents to her name, she has made remarkable advancements that enhance the efficiency and accuracy of genomic research.
Latest Patents
Among her latest patents is a method titled "Sequence tag directed subassembly of short sequencing reads into long sequencing reads." This innovative approach focuses on preparing a DNA sequencing library that optimally brings distal fragmentation breakpoints into close proximity to the non-degenerate sequence tag. The method involves circularizing a target fragment library with a variety of adaptor molecules, resulting in a population of first circularized double-stranded DNA molecules. This technique is particularly beneficial for sequencing platforms that perform best with shorter template molecules, typically less than 500 base pairs in length.
Another notable patent is "Error detection in sequence tag directed sequencing reads." This invention outlines methods for preparing DNA sequencing libraries by assembling short read sequencing data into longer contiguous sequences. This advancement is crucial for genome assembly, full-length cDNA sequencing, metagenomics, and the analysis of repetitive sequences within assembled genomes.
Career Highlights
Emily Turner is affiliated with the University of Washington, where she continues to push the boundaries of genetic research. Her work has not only contributed to the scientific community but has also paved the way for future innovations in DNA sequencing technologies.
Collaborations
Emily has collaborated with esteemed colleagues such as Jay Ashok Shendure and Joseph Brian Hiatt, further enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Emily Turner's innovative work in DNA sequencing technologies exemplifies her dedication to advancing genetic research. Her patents reflect a commitment to improving the methods used in genomic studies, making her a key figure in the field.